As of May 25
| -0.0003 / -0.13%|
The 2 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 6.50, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a +2,726.09% increase from the last price of 0.23.
The current consensus among 2 polled investment analysts is to Buy stock in Anthera Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.